Eugenio Gaudio

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Pyrrolo[2′,3′:3,4]cyclohepta[1,2-d][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell Types”.

Pyrrolo[2′,3′:3,4]cyclohepta[1,2-d][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell Types

Journal of Medicinal Chemistry(2020)10.1021/acs.jmedchem.0c01315

N/A

0DataRank · unranked

54 citations

Roberta Rocca, Marilia Barreca, Daniele Giallombardo, Alessandra Montalbano, Anna Carbone +11 more

Understanding the mechanism of action of pyrrolo[3,2-b]quinoxaline-derivatives as kinase inhibitors

RSC Medicinal Chemistry(2020)10.1039/d0md00049c

N/A

0DataRank · unranked

7 citations

Claudia Jessen‐Trefzer, Dimitrios Spiliotopoulos, Eugenio Gaudio, Chiara Tarantelli, Jing Dong +11 more

Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomas

European Journal of Medicinal Chemistry(2022)10.1016/j.ejmech.2022.114744

N/A

0DataRank · unranked

45 citations

Virginia Spanò, Roberta Rocca, Roberta Bivacqua, Anne‐Catherine Abel, Annalisa Maruca +14 more

Resistance to PI3Kδ inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6/PDGFRA axis

Haematologica(2022)10.3324/haematol.2021.279957

N/A

0DataRank · unranked

30 citations

Sara Napoli, Luciano Cascione, Giulio Sartori, Laura Barnabei, Eugenio Gaudio +20 more

Identification of pyrrolo[3′,4’:3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas

European Journal of Medicinal Chemistry(2023)10.1016/j.ejmech.2023.115372

N/A

0DataRank · unranked

33 citations

Virginia Spanò, Roberta Rocca, Roberta Bivacqua, Gianmarco Gualtieri, Maria Valeria Raimondi +11 more

ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.01.522017

N/A

0DataRank · unranked

2 citations

Sara Napoli, Luciano Cascione, Laura Barnabei, Giulio Sartori, Eleonora Cannas +19 more

Data from Frequent Attenuation of the WWOX Tumor Suppressor in Osteosarcoma Is Associated with Increased Tumorigenicity and Aberrant RUNX2 Expression

(2023)10.1158/0008-5472.c.6500696

N/A

0DataRank · unranked

0 citations

Sara Del Mare, Zaidoun Salah, Suhaib K. Abdeen, Hussain Sadiq, Suk‐Hee Lee +12 more

PI3Kδ activation, IL-6 overexpression, and CD37 loss cause resistance to naratuximab emtansine in lymphomas

Blood Advances(2024)10.1182/bloodadvances.2023012291

N/A

0DataRank · unranked

8 citations

Sara Napoli, Eugenio Gaudio, Charles Herbaux, Eleonora Cannas, Chiara Tarantelli +16 more